Dr. Guy S. Strauss

Intensive Care Medicine
Southern Internal Medicine
404 NW Hall Of Fame Dr, 
Lake City, FL 
Accepting New Patients
Offers Telehealth
Southern Internal Medicine
404 NW Hall Of Fame Dr, 
Lake City, FL 

Overview

Guy Strauss is an Intensive Care Medicine provider practicing medicine in Lake City, Florida.

His clinical expertise encompasses Vitamin D Deficiency, Menopause, Median Arcuate Ligament Syndrome (MALS), and Folliculitis.

He is actively involved in clinical research, co-authoring 1 peer reviewed article and participating in 8 clinical trials. Dr. Strauss is currently accepting new patients.

Specialties

Intensive Care Medicine

Licenses

Internal Medicine in SC

Hospital Affiliations

Hca Florida North Florida Hospital
Uf Health Shands Hospital
Hca Florida Lake City Hospital

Languages Spoken

English

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
AvMed
  • HMO
  • POS
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Blue Shield of California
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Cambia Health Solutions
  • EPO
  • INSURANCE PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • PPO
CareFirst
  • HMO
  • POS
  • PPO
Change Healthcare
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Cigna
  • EPO
  • HMO
  • PPO
EmblemHealth
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER COMMERCIAL
  • OTHER MEDICARE PART D
Florida Blue
  • EPO
  • PPO
Health Alliance Plan
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Health Options
  • HMO
  • POS
  • PPO
Highmark
  • EPO
  • HMO
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Premera Blue Cross
  • INSURANCE PLAN
  • MEDICARE MAPD
  • OTHER COMMERCIAL
  • PPO
Sunshine Health
  • EPO
  • HMO
TeamCare
  • OTHER COMMERCIAL
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Walgreens
  • MEDICARE DISCOUNT CARD
  • MEDICARE PDP
  • OTHER MEDICARE
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 19 Less Insurance Carriers -

Locations

Southern Internal Medicine
404 NW Hall Of Fame Dr, Lake City, FL 32055

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

8 Clinical Trials

Evaluation of the ctDNA LUNAR Test in an Average Patient Screening Episode
Evaluation of the ctDNA LUNAR Test in an Average Patient Screening Episode
Enrollment Status: Active_not_recruiting
Publish Date: May 14, 2026
A Phase 3, Multicenter, Randomized, Double-Blind, Parallel, Placebo-Controlled Induction Study of Mirikizumab in Conventional-Failed and Biologic-Failed Patients With Moderately to Severely Active Ulcerative Colitis (LUCENT 1)
A Phase 3, Multicenter, Randomized, Double-Blind, Parallel, Placebo-Controlled Induction Study of Mirikizumab in Conventional-Failed and Biologic-Failed Patients With Moderately to Severely Active Ulcerative Colitis (LUCENT 1)
Enrollment Status: Completed
Publish Date: May 31, 2025
Intervention Type: Drug
Study Drug: Mirikizumab
Study Phase: Phase 3
A Randomized, Double-Blind, Parallel Group, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy, Safety, and Tolerability of STS101 (Dihydroergotamine Nasal Powder) in the Acute Treatment of Migraine
A Randomized, Double-Blind, Parallel Group, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy, Safety, and Tolerability of STS101 (Dihydroergotamine Nasal Powder) in the Acute Treatment of Migraine
Enrollment Status: Completed
Publish Date: November 27, 2023
Intervention Type: Drug
Study Drug: Dihydroergotamine
Study Phase: Phase 3
A Phase III Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Ensifentrine Over 24 Weeks (With a 48-week Safety Subset) in Subjects With Moderate to Severe COPD
A Phase III Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Ensifentrine Over 24 Weeks (With a 48-week Safety Subset) in Subjects With Moderate to Severe COPD
Enrollment Status: Completed
Publish Date: November 13, 2023
Intervention Type: Drug
Study Drug: Ensifentrine
Study Phase: Phase 3
Blood Collection Sub-Study of Exact Sciences Protocol 2019-01: Clinical Validation of an Optimized Multi-Target Stool DNA (Mt-sDNA 2.0) Test, For Colorectal Cancer Screening BLUE-C
Blood Collection Sub-Study of Exact Sciences Protocol 2019-01: Clinical Validation of an Optimized Multi-Target Stool DNA (Mt-sDNA 2.0) Test, For Colorectal Cancer Screening BLUE-C
Enrollment Status: Completed
Publish Date: September 28, 2023
Intervention Type: Other
Clinical Validation of An Optimized Multi-Target Stool DNA (Mt-sDNA 2.0) Test, for Colorectal Cancer Screening BLUE-C
Clinical Validation of An Optimized Multi-Target Stool DNA (Mt-sDNA 2.0) Test, for Colorectal Cancer Screening BLUE-C
Enrollment Status: Completed
Publish Date: September 01, 2023
Intervention Type: Procedure, Diagnostic test
An Open-Label, 12-Month Study to Evaluate the Safety and Tolerability of STS101 (Dihydroergotamine Nasal Powder) in the Acute Treatment of Migraine
An Open-Label, 12-Month Study to Evaluate the Safety and Tolerability of STS101 (Dihydroergotamine Nasal Powder) in the Acute Treatment of Migraine
Enrollment Status: Completed
Publish Date: July 03, 2023
Intervention Type: Drug
Study Drug: Dihydroergotamine
Study Phase: Phase 3
EMERGE: A Randomized, Double-Blind, Parallel Group, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy, Safety, and Tolerability of Single Doses of STS101 (Dihydroergotamine Nasal Powder) in the Acute Treatment of Migraine
EMERGE: A Randomized, Double-Blind, Parallel Group, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy, Safety, and Tolerability of Single Doses of STS101 (Dihydroergotamine Nasal Powder) in the Acute Treatment of Migraine
Enrollment Status: Completed
Publish Date: June 29, 2023
Intervention Type: Drug
Study Phase: Phase 3
View 7 Less Clinical Trials

1 Total Publications

Clinical performance of Abbott ID NOW™ COVID-19 2.0 rapid molecular point-of-care test compared to three real-time RT-PCR assays.
Clinical performance of Abbott ID NOW™ COVID-19 2.0 rapid molecular point-of-care test compared to three real-time RT-PCR assays.
Journal: Microbiology spectrum
Published: February 11, 2025
Similar Doctors
Expertise in
5
conditions
Dr. Hiren J. Mehta
Intensive Care Medicine
Expertise in
5
conditions
Dr. Hiren J. Mehta
Intensive Care Medicine
Referral may be required
Before you request

Uf Health Medical Specialties-Medical Plaza

1549 Gale Lemerand Dr, 
Gainesville, FL 
 (43.1 miles away)
352-273-8740
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Hiren Mehta is an Intensive Care Medicine provider practicing medicine in Gainesville, Florida. Dr. Mehta is highly rated in 5 conditions, according to our data. His clinical expertise encompasses Lung Nodules, ALK-Positive Non-Small Cell Lung Cancer, Emphysema, Endoscopy, and Gastrostomy. Dr. Mehta is currently accepting new patients.

Expertise in
4
conditions
Dr. Michael A. Jantz
Intensive Care Medicine
Expertise in
4
conditions
Dr. Michael A. Jantz
Intensive Care Medicine
Referral may be required

North Florida Surgical Associates LLC

1121 NW 64th Ter Ste A, 
Gainesville, FL 
 (39.9 miles away)
352-331-5026
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Michael Jantz is an Intensive Care Medicine provider practicing medicine in Gainesville, Florida. Dr. Jantz is highly rated in 4 conditions, according to our data. His clinical expertise encompasses Lung Nodules, Emphysema, ALK-Positive Non-Small Cell Lung Cancer, Endoscopy, and Gastrostomy. Dr. Jantz is currently accepting new patients.

Expertise in
3
conditions
Dr. Jorge E. Lascano
Intensive Care Medicine
Expertise in
3
conditions
Dr. Jorge E. Lascano
Intensive Care Medicine
Referral may be required
Before you request

Uf Health Medical Specialties-Medical Plaza

1549 Gale Lemerand Dr, 
Gainesville, FL 
 (43.1 miles away)
352-273-8740
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Jorge Lascano is an Intensive Care Medicine provider practicing medicine in Gainesville, Florida. Dr. Lascano is highly rated in 3 conditions, according to our data. His clinical expertise encompasses Emphysema, Nontuberculous Mycobacterial Lung Disease, Secondary Immunodeficiency (SID), and Liver Failure. Dr. Lascano is currently accepting new patients.

Frequently Asked Questions about Dr. Guy S. Strauss

Is Dr. Guy S. Strauss a top-rated expert for Vitamin D Deficiency?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Guy S. Strauss is classified as an Experienced expert for Vitamin D Deficiency, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Guy S. Strauss specialize in?

While Dr. Guy S. Strauss is a Intensive Care Medicine, they have specific expertise in Vitamin D Deficiency, Menopause, and Median Arcuate Ligament Syndrome (MALS). MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Intensive Care Medicine.

Does Dr. Guy S. Strauss participate in research or clinical trials?

Yes. Dr. Guy S. Strauss has published 1 articles and abstracts on conditions like Vitamin D Deficiency. You can view a list of Dr. Guy S. Strauss's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Guy S. Strauss accept my insurance?

Dr. Guy S. Strauss accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Strauss's expertise for a condition
ConditionClose
        View All 17 Experienced Conditions
        Want to save this doctor for later?
        Sign Up
        Is this your doctor?
        Find A Second Opinion
        Not sure about your diagnosis?
        Check Your Symptoms
         
         
         
         
        Learn about our expert tiers
        Learn More
        Are you the provider on this profile?
        Claim Profile